Phase II study of paclitaxel in pretreated advanced gastric cancer

Article Properties
  • Language
    English
  • DOI (url)
    10.1097/00001813-199804000-00003
  • Publication Date
    1998/04/01
  • Journal
    Anti-Cancer Drugs
  • Indian UGC (journal)
  • Citations
    67
  • Stefano Cascinu
  • Francesco Graziano
  • Nadia Cardarelli
  • Massimo Marcellini
  • Paolo Giordani
  • Ettore Tito Menichetti
  • Giuseppina Catalano
Cite
Cascinu, Stefano, et al. “Phase II Study of Paclitaxel in Pretreated Advanced Gastric Cancer”. Anti-Cancer Drugs, vol. 9, no. 4, 1998, pp. 307-10, https://doi.org/10.1097/00001813-199804000-00003.
Cascinu, S., Graziano, F., Cardarelli, N., Marcellini, M., Giordani, P., Menichetti, E. T., & Catalano, G. (1998). Phase II study of paclitaxel in pretreated advanced gastric cancer. Anti-Cancer Drugs, 9(4), 307-310. https://doi.org/10.1097/00001813-199804000-00003
Cascinu S, Graziano F, Cardarelli N, Marcellini M, Giordani P, Menichetti ET, et al. Phase II study of paclitaxel in pretreated advanced gastric cancer. Anti-Cancer Drugs. 1998;9(4):307-10.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
Citations
Title Journal Journal Categories Citations Publication Date
Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer Cureus 2023
Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)

 International Journal of Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 14 2020
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol

 BMJ Open
  • Medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
 6 2019
Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer

 Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 5 2018
A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)

 The Oncologist
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 21 2018
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)58
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens51
Medicine: Therapeutics. Pharmacology12
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology7
Medicine: Public aspects of medicine: Toxicology. Poisons4
Medicine: Medicine (General): Medical technology3
Technology: Chemical technology: Biotechnology2
Medicine: Internal medicine2
Medicine: Surgery2
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Medicine: Nursing1
Medicine: Internal medicine: Special situations and conditions: Sports medicine1
Medicine: Public aspects of medicine1
Medicine1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
The category Medicine: Medicine (General) 58 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Paclitaxel loaded poly(l-lactic acid) microspheres for the prevention of intraperitoneal carcinomatosis after a surgical repair and tumor cell spill and was published in 2000. The most recent citation comes from a 2023 study titled Comparison of Two Chemotherapy Regimens After First-Line Treatment for HER2-Negative Metastatic Gastric Cancer. This article reached its peak citation in 2005, with 8 citations. It has been cited in 37 different journals, 8% of which are open access. Among related journals, the Cancer Chemotherapy and Pharmacology cited this research the most, with 8 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year